Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125827693 | 12582769 | 3 | F | 20160913 | 20160722 | 20160926 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-120672 | RANBAXY | 61.00 | YR | F | Y | 0.00000 | 20160926 | OT | GB | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125827693 | 12582769 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10 MG AT 3:15 PM | U | 91038 | |||||||||
| 125827693 | 12582769 | 2 | I | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10 MG, DAILY | U | 91038 | 10 | MG | |||||||
| 125827693 | 12582769 | 3 | I | OLANZAPINE. | OLANZAPINE | 1 | U | 91038 | |||||||||||
| 125827693 | 12582769 | 4 | I | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG AT 1:00 PM | U | 0 | |||||||||
| 125827693 | 12582769 | 5 | I | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG, DAILY, 2-3 TIMES DAILY | U | 0 | 1 | MG | |||||||
| 125827693 | 12582769 | 6 | I | LORAZEPAM. | LORAZEPAM | 1 | U | 0 | |||||||||||
| 125827693 | 12582769 | 7 | I | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 1 MG | U | 0 | |||||||||
| 125827693 | 12582769 | 8 | I | LORAZEPAM. | LORAZEPAM | 1 | U | 0 | |||||||||||
| 125827693 | 12582769 | 9 | I | LORAZEPAM. | LORAZEPAM | 1 | U | 0 | |||||||||||
| 125827693 | 12582769 | 10 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 2000 MG/M2 OVER 46 HOURS | U | 0 | INFUSION | ||||||||
| 125827693 | 12582769 | 11 | C | Folinic acid | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
| 125827693 | 12582769 | 12 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 60 MG/M2 OVER 2 HOURS | U | 0 | INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125827693 | 12582769 | 1 | Product used for unknown indication |
| 125827693 | 12582769 | 2 | Nausea |
| 125827693 | 12582769 | 3 | Prophylaxis of nausea and vomiting |
| 125827693 | 12582769 | 4 | Anxiety |
| 125827693 | 12582769 | 5 | Anxiety |
| 125827693 | 12582769 | 6 | Nausea |
| 125827693 | 12582769 | 7 | Premedication |
| 125827693 | 12582769 | 8 | Anxiety |
| 125827693 | 12582769 | 9 | Nausea |
| 125827693 | 12582769 | 10 | Pancreatic carcinoma |
| 125827693 | 12582769 | 11 | Pancreatic carcinoma |
| 125827693 | 12582769 | 12 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125827693 | 12582769 | HO |
| 125827693 | 12582769 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125827693 | 12582769 | Delirium | |
| 125827693 | 12582769 | Drug interaction | |
| 125827693 | 12582769 | Hypotension | |
| 125827693 | 12582769 | Respiratory depression | |
| 125827693 | 12582769 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |